JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

InhonorofJPMWeek,you’rereadingaspecialeditionofourbiotechnewsletter,TheReadout.Tostayontopofthelates AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger




entertainment

author：knowledge    Page View：7
David Liu- Broad Retreat
David Liu proposed prime editing of genes in 2019. The technology has passed a big test. Courtesy ErikJacobs/Broad Institute

Prime Medicine said Friday it successfully used a new, ultra-versatile form of genetic surgery called prime editing to edit liver cells in monkeys.

The results, presented at the European Society of Gene & Cell Therapy meeting in Brussels, are a major step for a technology that could transform treatment of numerous diseases.

advertisement

“I think the big celebration here is we’re showing, in primates, for the company, that we have a delivery system that is working and is safe,” said Jeremy Duffield, Prime’s chief scientific officer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Hospital chaplains balance Covid safety with patients’ spiritual needs
Next article： Tori Bowie and the unacceptable rates of Black maternal death